The impact of METTL3 and NEDD1 on DLBCL tumorigenesis was examined in vivo (only SU‐DHL‐8 cells were used for in vivo experiments to reduce unnecessary sacrifices). The gene discussed is NEDD1; the disease is diffuse large B-cell lymphoma.